Literature DB >> 19169714

Detection by multiplex ligation-dependent probe amplification of large deletion mutations in the COL4A5 gene in female patients with Alport syndrome.

Kandai Nozu, Rafal Przybyslaw Krol, Koichi Nakanishi, Norishige Yoshikawa, Yoshimi Nozu, Yasufumi Ohtsuka, Kazumoto Iijima, Masafumi Matsuo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19169714     DOI: 10.1007/s00467-009-1122-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  7 in total

1.  Alport syndrome with diffuse leiomyomatosis. When and when not?

Authors:  J H Miner
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

Review 2.  Alport syndrome.

Authors:  C E Kashtan; A F Michael
Journal:  Kidney Int       Date:  1996-11       Impact factor: 10.612

3.  Detection of large deletion mutations in the COL4A5 gene of female Alport syndrome patients.

Authors:  Kandai Nozu; Rafal Przybyslaw Krol; Yasufumi Ohtsuka; Koichi Nakanishi; Norishige Yoshikawa; Yoshimi Nozu; Hiroshi Kaito; Kyoko Kanda; Yuya Hashimura; Yuhei Hamasaki; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2008-06-27       Impact factor: 3.714

4.  Smooth muscle tumors associated with X-linked Alport syndrome: carrier detection in females.

Authors:  K Dahan; L Heidet; J Zhou; G Mettler; K A Leppig; W Proesmans; A David; B Roussel; J G Mongeau; J M Gould
Journal:  Kidney Int       Date:  1995-12       Impact factor: 10.612

5.  MLPA and cDNA analysis improves COL4A5 mutation detection in X-linked Alport syndrome.

Authors:  J M Hertz; I Juncker; N Marcussen
Journal:  Clin Genet       Date:  2008-06-26       Impact factor: 4.438

6.  Molecular analysis of digenic inheritance in Bartter syndrome with sensorineural deafness.

Authors:  K Nozu; T Inagaki; X J Fu; Y Nozu; H Kaito; K Kanda; T Sekine; T Igarashi; K Nakanishi; N Yoshikawa; K Iijima; M Matsuo
Journal:  J Med Genet       Date:  2008-03       Impact factor: 6.318

7.  Molecular analysis of patients with type III Bartter syndrome: picking up large heterozygous deletions with semiquantitative PCR.

Authors:  Kandai Nozu; Xue Jun Fu; Koichi Nakanishi; Norishige Yoshikawa; Hiroshi Kaito; Kyoko Kanda; Rafal Przybyslaw Krol; Ritsuko Miyashita; Hidekazu Kamitsuji; Shoichiro Kanda; Yoshiki Hayashi; Kenichi Satomura; Nobuhiko Shimizu; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Res       Date:  2007-09       Impact factor: 3.756

  7 in total
  4 in total

1.  Characterization of contiguous gene deletions in COL4A6 and COL4A5 in Alport syndrome-diffuse leiomyomatosis.

Authors:  Kandai Nozu; Shogo Minamikawa; Shiro Yamada; Masafumi Oka; Motoko Yanagita; Naoya Morisada; Shuichiro Fujinaga; China Nagano; Yoshimitsu Gotoh; Eihiko Takahashi; Takahiro Morishita; Tomohiko Yamamura; Takeshi Ninchoji; Hiroshi Kaito; Ichiro Morioka; Koichi Nakanishi; Igor Vorechovsky; Kazumoto Iijima
Journal:  J Hum Genet       Date:  2017-03-09       Impact factor: 3.172

2.  Recurrent deep intronic mutations in the SLC12A3 gene responsible for Gitelman's syndrome.

Authors:  Yi-Fen Lo; Kandai Nozu; Kazumoto Iijima; Takahiro Morishita; Che-Chung Huang; Sung-Sen Yang; Huey-Kang Sytwu; Yu-Wei Fang; Min-Hua Tseng; Shih-Hua Lin
Journal:  Clin J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 8.237

3.  Development of multiplex PCR method for the analysis of glutathione s-transferase polymorphism.

Authors:  Min Sun Kim; Hyoung Jin Kang; Han Jeong Park; Yeon-Joo Yook; Byoung-Don Han; Chul Woo Kim; Nam Hee Kim; Ji Won Lee; Hyery Kim; Kyung Duk Park; Hee Young Shin; Hyo Seop Ahn
Journal:  Mol Diagn Ther       Date:  2011-10-01       Impact factor: 4.074

Review 4.  Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome.

Authors:  Kandai Nozu; Yutaka Takaoka; Hirofumi Kai; Minoru Takasato; Kensuke Yabuuchi; Tomohiko Yamamura; Tomoko Horinouchi; Nana Sakakibara; Takeshi Ninchoji; China Nagano; Kazumoto Iijima
Journal:  Kidney Res Clin Pract       Date:  2020-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.